Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development

Quantitative PCR for Detection of Shigella Improves Ascertainment of Shigella Burden in Children with Moderate-to-Severe Diarrhea in Low-Income Countries

(2013) B. Lindsay et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

(2013) Karen L Kotloff et al.   LANCET

Progress and pitfalls in Shigella vaccine research

(2013) Eileen M. Barry et al.   Nature Reviews Gastroenterology & Hepatology

Housefly Population Density Correlates with Shigellosis among Children in Mirzapur, Bangladesh: A Time Series Analysis

(2013) Tamer H. Farag et al.   PLoS Neglected Tropical Diseases

Stockpiling oral cholera vaccine

(2012) Stephen Martin et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Some Epidemiologic, Clinical, Microbiologic, and Organizational Assumptions That Influenced the Design and Performance of the Global Enteric Multicenter Study (GEMS)

(2012) Tamer H. Farag et al.   CLINICAL INFECTIOUS DISEASES

The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control Study

(2012) Karen L. Kotloff et al.   CLINICAL INFECTIOUS DISEASES

The Global Enteric Multicenter Study (GEMS): Impetus, Rationale, and Genesis

(2012) M. M. Levine et al.   CLINICAL INFECTIOUS DISEASES

Diagnostic Microbiologic Methods in the GEMS-1 Case/Control Study

(2012) Sandra Panchalingam et al.   CLINICAL INFECTIOUS DISEASES

Structural elucidation of the O-antigen of the Shigella flexneri provisional serotype 88-893: structural and serological similarities with S. flexneri provisional serotype Y394 (1c)

(2011) R.A. Foster et al.   CARBOHYDRATE RESEARCH

Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins

(2011) Francisco J. Martinez-Becerra et al.   INFECTION AND IMMUNITY

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

(2010) Justen H. Passwell et al.   VACCINE